Founder: Yelena Budovskaya
TruMe Inc. is on the mission is to extend individual lifespan through early detection of health deterioration and development of age-related diseases. TruMe has developed a new, simple, unique, epigenetic test -TruAge Index - to determine and monitor changes in one's biological age and rate of aging. The analysis based on a saliva sample and a blood draw are not required. The science behind the test states that our cells (even healthy ones) age at the faster rate if they develop diseases or chronic conditions, and TruMe test can detect it.
Yelena Budovskaya is a Co-founder and CEO of TruMe Inc. Yelena is a well known aging researcher. She received her Ph.D. in Molecular Genetics from the Ohio State University and postdoctoral training at Stanford University. Prior founding TruMe Inc, Yelena has run a successful research program that investigates the genetic basis of the natural aging process at the University of Amsterdam. Also, Yelena worked as a Senior scientist at uBiome, where she developed a sequence-based method of characterization of human health microbiome. Yelena is a big proponent of citizen science platform to encouraging public participation in research and disease prevention. Yelena developed and together with her co-founder, Oleksandr Demidenko, validated TruAge technology on over 100 users. The TruAge teast is openly available from the TruMe website.